Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach a valuation of US$ 21.48 Bn by 2031 NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease...

Global Psoriasis Drugs Market is estimated to be US$ 37.07 Billion in 2030 at a CAGR 8.9% during the forecast period - By PMI Covina, Feb. 10, 2022 (GLOBE NEWSWIRE) --  Global Psoriasis Drugs Market accounted for US$ 15.85 billion in 2020 and is estimated to be US$ 37.07 billion by 2030 and is anticipated to register a...

Psoriasis Drugs Market To Reach USD 39.00 Billion By 2027 | Reports And Data New York, Jan. 22, 2020 (GLOBE NEWSWIRE) -- The global psoriasis drugs market is forecast to reach USD 39.00 Billion by 2027, according to a new report by Reports and Data. Psoriasis can be defined...

Psoriasis Drugs Market to Witness Steady Growth of US$ 6,509 Mn by 2028 - PMR New York, July 08, 2019 (GLOBE NEWSWIRE) -- The growth of the psoriasis drugs market is attributed to the growing use of topical corticosteroids products and psoriasis treatment across the globe....